The latest news and stats on sleep apnea and respiratory care from
ResMed, the world's leading tech-driven medical device company. 

The AirTouch F20 with UltraSoft memory foam, our softest mask ever

View the full press kit

Latest news

Latest news

October 15, 2017

ATLANTA -- October 15, 2017 -- Brightree®, a leading provider of cloud-based software that improves clinical and business performance of post-acute care companies, today announced that it has...

October 12, 2017

ResMed's AirSense 10, AirCurve 10 and Lumis products do not infringe German utility model patent MUNICH, Oct. 12, 2017 /PRNewswire/ -- ResMed (NYSE: RMD), the world's leading tech-driven medical...

October 6, 2017

ResMed (NYSE: RMD) the world's leading tech-driven medical device company and innovator in sleep-disordered breathing and respiratory care, today announced the following updates in its ongoing...

See all news releases

Fast facts - Landing Page

Fast facts

  • 1,250
    CPAP users a day sign up for myAir to self monitor their treatment.
  • +3 MILLION
    people remotely monitored on cloud connected CPAP machines and ventilators every night.
  • +11 MILLION
    lives changed by a ResMed device, mask or accessory.

See all fast facts

In the news

In the news

October 2, 2017
Seeking Alpha
September 14, 2017
San Diego Business Journal

See all articles

Infographics - Landing Page


Learn about respiratory conditions, their effects on our health and communities,
and how ResMed helps millions live and breathe better.


See all infographics

Media resources - Gray, Left - Landing Page

Media resources

Find everything you need.
Ask us for more information.

See all resources

Media contacts - Gray, Right - Landing Page

Media contacts


Alison Graves
(858) 836-6789



Jayme Rubenstein
(858) 836-6798


EMEA, Japan

Christine Many Lacoste
(33) 04-26-10-02-43



Paul McKeon
(61) 2-8884-2596


Questions? Site Feedback?

Email us

Email Alerts - Landing Page

Sign up to receive ResMed news releases when they publish.



ResMed provides a non-transferable, non-exclusive license to the copyrighted images, drawings and materials subject to the following Terms of Use.

All countries & languages